The vaccine-induced momentum persisted on the markets - Wednesday Review, November 25

The vaccine-induced momentum persisted on the markets - Wednesday Review, November 25

The majority of the global markets continued the rally

The US

The higher-than-expected number of unemployment claims impacted the markets: USA30 fell 0.58%, while USA500 was down 0.14%. TECH100 gained 0.47% as the rumor has it that Slack is to be purchased by Salesforce.

Crude Oil settled up 1.8% at $45.71 per barrel.

Gold added 0.3% settling at $1,810.30 per ounce.

Asia and Australia

The stocks closed in the green as optimism over a viable COVID-19 vaccine didn’t dissipate.

Japan225 surged 1.60%.

HongKong45 rose 1.51% as the city is expected to impose tighter measures to curb the number of COVID-19 infections.

Down under, Australia200 gained 0.84%.

Europe

The markets traded higher, still under the influence of the COVID-19 vaccine-induced momentum. Germany30 added 0.2%. France40 and UK100 each traded 0.5% higher.

Brent Oil went up 1.4% to $48.53 a barrel.

EUR/USD traded at 1.1919 after it added 0.3%.

Sources: reuters.com, investing.com

The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.